this randomized double-blind study evaluates systemic antifungal therapy with fluconazole ( 100 mg daily ) or ketoconazole ( 400-mg daily ) for oropharyngeal candidiasis in patients with cancer .
C0003308
antifungal
C0022625
ketoconazole